| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
BCR activator of RhoGEF and GTPase | 0.431 | 0.885 | 0.99 |
|
disease | 0.100 | None | 0.986 | 6 | 0 | 1980 | 2019 | ||||||||
|
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase | 0.427 | 0.885 |
|
disease | 0.080 | None | 1.000 | 1 | 0 | 1980 | 2019 | |||||||||
|
ABL proto-oncogene 1, non-receptor tyrosine kinase | 0.432 | 0.923 | 1.00 |
|
disease | 0.100 | None | 0.985 | 4 | 0 | 1983 | 2019 | ||||||||
|
interleukin 2 receptor subunit alpha | 0.389 | 0.885 | 5.5E-02 |
|
disease | 0.070 | None | 1.000 | 1 | 0 | 1983 | 2016 | ||||||||
|
cytochrome P450 family 1 subfamily A member 1 | 0.436 | 0.846 | 1.1E-17 |
|
disease | 0.080 | None | 0.875 | 1 | 0 | 1984 | 2013 | ||||||||
|
myeloperoxidase | 0.377 | 0.923 | 7.1E-15 |
|
disease | 0.100 | None | 0.952 | 1 | 0 | 1985 | 2018 | ||||||||
|
interleukin 2 | 0.336 | 0.885 | 0.48 |
|
disease | 0.400 | None | 1.000 | 1 | 0 | 1985 | 2019 | ||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
disease | 0.100 | None | 0.899 | 8 | 0 | 1986 | 2019 | ||||||||
|
ATP binding cassette subfamily B member 1 | 0.344 | 0.885 | 1.3E-05 |
|
disease | 0.100 | None | 0.947 | 5 | 0 | 1986 | 2020 | ||||||||
|
CD38 molecule | 0.407 | 0.885 | 2.3E-06 |
|
disease | 0.100 | None | 0.971 | 2 | 0 | 1986 | 2019 | ||||||||
|
lysine methyltransferase 2A | 0.410 | 0.885 | 1.00 |
|
disease | 0.400 | None | 0.997 | 13 | 0 | 1987 | 2020 | ||||||||
|
colony stimulating factor 2 | 0.330 | 0.962 | 0.83 |
|
disease | 0.100 | None | 1.000 | 1 | 0 | 1987 | 2019 | ||||||||
|
KRAS proto-oncogene, GTPase | 0.320 | 0.923 | 7.9E-04 |
|
disease | 0.200 | None | 0.900 | 1 | 0 | 1987 | 2020 | ||||||||
|
neural cell adhesion molecule 1 | 0.415 | 0.885 | 1.00 |
|
disease | 0.100 | None | 0.882 | 1 | 0 | 1988 | 2019 | ||||||||
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
disease | 0.100 | None | 0.974 | 2 | 0 | 1989 | 2018 | ||||||||
|
Raf-1 proto-oncogene, serine/threonine kinase | 0.418 | 0.885 | 0.85 |
|
disease | 0.100 | None | 1.000 | 1 | 0 | 1989 | 2017 | ||||||||
|
delta like canonical Notch ligand 1 | 0.492 | 0.808 | 1.00 |
|
disease | 0.050 | None | 0.800 | 1 | 0 | 1989 | 2003 | ||||||||
|
BCL2 apoptosis regulator | 0.291 | 0.885 | 0.56 |
|
disease | 0.100 | None | 0.991 | 5 | 0 | 1990 | 2020 | ||||||||
|
retinoic acid receptor alpha | 0.470 | 0.846 | 0.96 |
|
disease | 0.100 | None | 1.000 | 4 | 0 | 1990 | 2018 | ||||||||
|
interleukin 6 | 0.248 | 0.962 | 0.32 |
|
disease | 0.100 | None | 0.944 | 1 | 0 | 1990 | 2019 | ||||||||
|
MYB proto-oncogene, transcription factor | 0.490 | 0.692 | 0.82 |
|
disease | 0.100 | None | 1.000 | 1 | 0 | 1990 | 2019 | ||||||||
|
Fc fragment of IgE receptor II | 0.560 | 0.654 | 7.6E-12 |
|
disease | 0.040 | None | 1.000 | 1 | 0 | 1991 | 2019 | ||||||||
|
MYCN proto-oncogene, bHLH transcription factor | 0.454 | 0.808 | 0.89 |
|
disease | 0.030 | None | 1.000 | 1 | 0 | 1991 | 2008 | ||||||||
|
alanyl aminopeptidase, membrane | 0.462 | 0.769 | 3.7E-09 |
|
disease | 0.100 | None | 0.900 | 1 | 0 | 1991 | 2012 | ||||||||
|
proteinase 3 | 0.503 | 0.808 | 3.8E-05 |
|
disease | 0.060 | None | 1.000 | 1 | 0 | 1991 | 2019 |